NCT07605078

Brief Summary

The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
35mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Apr 2029

Study Start

First participant enrolled

April 27, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

May 18, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2029

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

2.9 years

First QC Date

May 18, 2026

Last Update Submit

May 18, 2026

Conditions

Mold IllnessMold or Dust Allergy

Keywords

Mold

Outcome Measures

Primary Outcomes (1)

  • PROMIS - Global Health

    Ten questions assessing physical and mental health. Higher scores indicate superior physical and mental health.

    Assessed at the time that the mold test is collected (cross-sectional)

Secondary Outcomes (2)

  • Mold-related symptoms

    Assessed at the time that the mold test is collected (cross-sectional)

  • Mycotoxin levels

    Assessed at the time that the mold test is collected (cross-sectional)

Interventions

Mold-specific quantitative PCR (MSQPCR) testingOTHER

The Dust Test is mold-specific quantitative PCR (MSQPCR) analysis that is being utilized to evaluate the associations between household mold organisms and a variety of human health outcomes.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.

You may qualify if:

  • All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.

You may not qualify if:

  • Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OvationLab

Richmond, Virginia, 23220, United States

Location

Central Study Contacts

Study Administrator

CONTACT

‪(240) 232-2103‬info@ovationlab.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
5 Years
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2026

First Posted

May 22, 2026

Study Start

April 27, 2026

Primary Completion (Estimated)

April 1, 2029

Study Completion (Estimated)

April 1, 2029

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Mold results and participant-reported outcomes

Locations

US(1)